Segment 1 - Immuno-Oncology Education Outreach Efforts

Surabhi Dangi-Garimella, PhD, managing editor of The American Journal of Managed Care’s Evidence-Based series led the panel of experts in a discussion on immuno-oncology by first talking about checkpoint inhibitors currently in the market and under development.

Kimberly Shafer-Weaver, PhD, explained that in order to keep providers and patients more aware of the latest developments, there needs to be a better outreach effort at meetings and other venues to educate people about immunotherapists and how they can be used.